title: [Type IIa dyslipoproteinemia. Effects of simvastatin and bezafibrate on atherogenic and non-atherogenic lipoprotein particles].
authors.forename: J M
authors.initials: JM
authors.lastname: Lecerf
authors.forename: J M
authors.initials: JM
authors.lastname: Bard
authors.forename: V
authors.initials: V
authors.lastname: Leclerc
authors.forename: P
authors.initials: P
authors.lastname: Douste-Blazy
authors.forename: B
authors.initials: B
authors.lastname: Devulder
authors.forename: C
authors.initials: C
authors.lastname: Harvengt
authors.forename: J C
authors.initials: JC
authors.lastname: Fruchart
mesh_terms: D001629:Bezafibrate / Q000494:pharmacology*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood*; D006938:Hyperlipoproteinemia Type II / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000494:pharmacology; D019821:Simvastatin
chemical_list: D008074:Lipoproteins; D008148:Lovastatin; D019821:Simvastatin; D001629:Bezafibrate
vernacular_title: Dyslipoprotéinémies de type IIa. Effets de la simvastatine et du bézafibrate sur les particules lipoprotéiques athérogènes et non athérogènes.